Belatacept is a fusion protein used as an immunosuppressant to prevent organ rejection in kidney transplant recipients. It selectively blocks T-cell activation by binding to CD80 and CD86 on antigen-presenting cells. It is grouped under the following drug class(es): Immunosuppressants. Its therapeutic use is listed as anti-inflammatories. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Nulojix, belataceptum and LEA 29Y. Its PubChem SID is 480409563.
Belatacept
| CAS No | 706808-37-9 |
|---|---|
| Molecular Formula | N/A |
| Molecular Weight | 79,092.39 g/mol |
| Synonyms | N/A |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Belatacept is a fusion protein used as an immunosuppressant to prevent organ rejection in kidney transplant recipients. It selectively blocks T-cell activation by binding to CD80 and CD86 on antigen-presenting cells.
The listed CAS number is 706808-37-9.
The listed molecular formula is N/A.
The listed molecular weight is 79,092.39 g/mol.
N/A.
The source lists Nulojix, belataceptum and LEA 29Y.